APA (7th ed.) Citation

J, S., L, L., L, D., F, Y., H, M., K, W., & Q, L. (2026). Targeting lineage-specific heterogeneity and hypovascular-fibrotic barriers may enable precision immunotherapy in pituitary neuroendocrine tumors. Frontiers in immunology, 17, 1796402. https://doi.org/10.3389/fimmu.2026.1796402

Chicago Style (17th ed.) Citation

J, Song, Li L, Ding L, Yang F, Mao H, Wang K, and Li Q. "Targeting Lineage-specific Heterogeneity and Hypovascular-fibrotic Barriers May Enable Precision Immunotherapy in Pituitary Neuroendocrine Tumors." Frontiers in Immunology 17 (2026): 1796402. https://doi.org/10.3389/fimmu.2026.1796402.

MLA (9th ed.) Citation

J, Song, et al. "Targeting Lineage-specific Heterogeneity and Hypovascular-fibrotic Barriers May Enable Precision Immunotherapy in Pituitary Neuroendocrine Tumors." Frontiers in Immunology, vol. 17, 2026, p. 1796402, https://doi.org/10.3389/fimmu.2026.1796402.